研究疾病:
|
抑郁障碍
|
研究疾病代码:
|
|
Target disease:
|
depression disorder
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
非随机对照试验
Non randomized control
|
研究所处阶段:
Study phase:
|
其它
Others
|
研究目的:
|
1.明确虚证抑郁障碍存在肾脏酸化功能下降及酸潴留,其抑郁严重程度与肾脏酸化功能及酸潴留相关。
2.明确虚证抑郁障碍存在犬尿氨酸代谢通路异常,并与肾脏酸化功能及酸潴留相关。
3.明确虚证抑郁障碍存在DNA甲基化异常,部分位点的异常与肾脏酸化功能及酸潴留相关。
4.验证扶阳解郁法治疗虚证抑郁障碍的疗效,其作用机制在于改善肾脏酸化功能及酸潴留,并恢复犬尿氨酸代谢通路和DNA甲基化的平衡。
5.明确中、西药治疗后,抑郁症状及效应指标的变化是否存在差异。
|
Objectives of Study:
|
1.To make clear that decreased renal acidification function and acid retention exist in depressive disorder with deficiency syndrome and the severity of depression is related to renal acidification function and acid retention.
2.To make clear that there is abnormal kynurenine metabolic pathway in depressive disorder with deficiency syndrome, which is related to renal acidification function and acid retention.
3. To make clear that DNA methylation abnormality exists in depressive disorder with deficiency syndrome, and some of abnormal DNA methylation sites are related to renal acidification function and acid retention.
4.To verify the efficacy of Fuyang Jieyu therapy in treating depression disorder with deficiency syndrome, its mechanism is to improve renal acidification function and acid retention, and restore the normality of kynurenine metabolic pathway and DNA methylation.
5. To demonstrate whether there are differences in the changes of depressive symptoms and effect indicators between the traditional Chinese medicine and Western medicine treatment.
|
药物成份或治疗方案详述:
|
治疗组分为西药组和中药组。西药组常规服用SSRI类或SNRIS类抗抑郁药,中药组服用扶阳解郁类方剂(虚劳方、桂附理中汤加减;早期可联合小剂量抗抑郁药,抑郁症状缓解后即予以停用,并记录联合使用药物情况),每日一剂治疗。
|
Description for medicine or protocol of treatment in detail:
|
The treatment groups are divided into western medicine group and traditional Chinese medicine group.Patients in the western medicine group routinely take SSRI or SNRIS antidepressants, while patients in the traditional Chinese medicine group take Fuyang Jieyu formulas, one dose a day. (modified Xu Lao formula or Gui Fu Li Zhong Soup; in the early stage, low-dose antidepressants could be used in combination and then they should be discontinued after the depressive symptoms are relieved. The combined use of drugs should be recorded.)
|
纳入标准:
|
1.虚证抑郁障碍患者入组标准:
1)符合《精神障碍诊断与统计手册(第五版)》(DSM-5)关于抑郁障碍的诊断标准;
2)按《中医诊断学》虚实证鉴别要点:从病程、体质、精神、声息、疼痛、胸腹胀满、发热、恶寒、舌象、脉象等方面鉴别为虚证;
3)不是由精神活性物质或器质性疾病引起;
4)16岁≤年龄≤60岁。
2.正常对照的入组标准:
1)既往身体健康,无躯体疾病,无精神障碍;
2)本次体检结果基本正常;
3)无睡眠障碍及消化功能异常;
4)近一周内无感染病史、饮酒,未服用利尿剂、抗酸剂、酸化剂及可影响胃肠吸收或肾脏排酸的药物。
|
Inclusion criteria
|
1.Inclusive criteria for the depression disorder with deficiency syndrome group were as follows:
(1) Current symptoms met the diagnosis of depression according to DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th revision)
(2) According to Diagnosis of Traditional Chinese Medicine, deficiency syndrome can be identified from the course of disease, constitution, spirit, voice, pain, distension of chest and abdomen, fever, aversion to cold, tongue, pulse and other aspects
(3) Not caused by psychoactive substances or organic diseases
(4) 16 years old ≤ age ≤ 60 years old.
2.Inclusion criteria for the healthy group were as follows:
(1) a good health record, no physical illness and psychiatric disorder
(2) Results have been normal in this examination
(3) no sleeping disorders and digestive dysfunction
(4) No history of infection, alcohol intake, taking diuretics, antacids, acidulants and drugs that can affect gastrointestinal absorption or renal acid excretion within the previous week
|
排除标准:
|
虚证抑郁障碍患者的排除标准:
1)酒精及精神活性物质滥用;
2)既往有符合症状标准的躁狂或轻躁狂发作;
3)妊娠、哺乳期女性患者;
4)合并明显心血管系统、呼吸系统、肝脏、肾脏、糖尿病等躯体疾病者;
5)近一周服用利尿剂、抗酸剂、酸化剂及可影响胃肠吸收或肾脏排酸的药物;
6)近一周内有感染病史者;
7)被限制在轮椅上活动的病人。
|
Exclusion criteria:
|
Exclusion criteria for the depression disorder with deficiency syndrome group were as follows:
(1) abuse of alcohol and psychoactive substances
(2) A previous episode of mania or hypomania that met symptom criteria
(3) pregnant or lactating female patients
(4) presence of obvious cardiovascular system, respiratory system, liver, kidney, diabetes and other physical diseases
(5) patients who took diuretics, antacids, acidulants and drugs that can affect gastrointestinal absorption or renal acid excretion in the previous week
(6) infection history within the past week
(7) patients confined to wheelchairs
|
研究实施时间:
Study execute time:
|
从From
2021-10-30
至To
2023-10-30
|
征募观察对象时间:
Recruiting time:
|
从From
2022-02-07
至To
2023-10-30
|